So, 3 or 4 months not unexpected, demonstrating precedent. Many thanks for looking LED.
The tone of today's ann seems to be at pains to suggest this may be the case for MSB too (listing prior successful prod facility inspection etc.). We shall see. As I won't be selling any until decision due to terminal laziness, I don't have timing risk or fomo.
- Forums
- ASX - By Stock
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
So, 3 or 4 months not unexpected, demonstrating precedent. Many...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.729B |
Open | High | Low | Value | Volume |
$1.48 | $1.54 | $1.45 | $6.072M | 4.049M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5951 | $1.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.52 | 133644 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5951 | 1.515 |
2 | 25946 | 1.510 |
3 | 69790 | 1.505 |
10 | 85830 | 1.500 |
5 | 49557 | 1.495 |
Price($) | Vol. | No. |
---|---|---|
1.520 | 133644 | 5 |
1.525 | 36900 | 5 |
1.530 | 108768 | 5 |
1.535 | 48010 | 6 |
1.540 | 113241 | 11 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online